Putnam BioRevolution ETF (SYNB)
AMEX: SYNB
· Real-Time Price · USD
30.66
0.78 (2.60%)
At close: Oct 01, 2025, 1:42 PM
2.60% (1D)
| Bid | 30.62 |
| Market Cap | 5.44M |
| AUM | 5.11M |
| NAV | 29.18 |
| EPS (ttm) | 1.04 |
| PE Ratio (ttm) | 29.38 |
| Shares Out | 177.56K |
| Inception Date | Sep 28, 2022 |
| Ask | 30.69 |
| Volume | 6,060 |
| Open | 30.29 |
| Previous Close | 29.88 |
| Day's Range | 30.29 - 30.69 |
| 52-Week Range | 24.57 - 32.81 |
| Holdings | 38 |
| Expense Ratio | 0.70% |
About SYNB
The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.
Asset Class Equity
Ticker Symbol SYNB
Inception Date Sep 28, 2022
Provider Putnam
Website Fund Home Page
Exchange AMEX
Top Sectors
| Sector | Weight % |
|---|---|
| Healthcare | 59.96% |
| Basic Materials | 23.67% |
| Technology | 8.78% |
| Consumer Defensive | 5.77% |
| Consumer Cyclical | 1.82% |
Top 10 Holdings 50.21% of assets
| Name | Symbol | Weight |
|---|---|---|
| Thermo Fisher Scient... | TMO | 8.01% |
| Abbvie Inc. | ABBV | 5.79% |
| Corteva, Inc. | CTVA | 5.77% |
| Nvidia Corporation | NVDA | 4.82% |
| Novozymes A/s | NVZMY | 4.78% |
| Ascendis Pharma A/s | ASND | 4.76% |
| Bio-rad Laboratories... | BIO | 4.32% |
| Astrazeneca PLC | AZN | 4.25% |
| Cadence Design Syste... | CDNS | 4.16% |
| Dupont De Nemours, I... | DD | 3.55% |
Dividends Dividend Yield 0.7%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 5, 2024 | $0.2139 | Dec 9, 2024 |
| Dec 6, 2023 | $0.0211 | Dec 11, 2023 |
